Education
About Us
Working with TipRanks
Follow Us
Immix Biopharma, Inc. (IMMX)
NASDAQ:IMMX
| Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ -89.52M | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ -5.47K | $ -89.52M | $ -2.47K | $ -2.32K | $ -1.08K |
| Operating Income | $ -16.14M | $ -8.22M | $ -1.35M | $ -453.85K | $ -842.50K |
| EBITDA | $ -16.14M | $ -8.22M | $ -1.35M | $ -451.53K | $ -841.20K |
| Net Income | $ -15.43M | $ -8.23M | $ -24.38M | $ -1.15M | $ -972.81K |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 17.51M | $ 13.44M | $ 17.64M | $ 391.09K | $ 734.01K |
| Total Assets | $ 19.93M | $ 14.91M | $ 18.19M | $ 539.60K | $ 942.94K |
| Total Debt | $ 0.00 | $ 0.00 | $ 50.00K | $ 4.10M | $ 4.10M |
| Net Debt | $ -17.51M | $ -13.44M | $ -17.59M | $ 3.71M | $ 3.37M |
| Total Liabilities | $ 3.72M | $ 1.75M | $ 202.04K | $ 5.27M | $ 4.59M |
| Stockholders' Equity | $ 16.41M | $ 13.16M | $ 17.99M | $ -4.73M | $ -3.65M |
| Cash Flow | |||||
| Free Cash Flow | $ -11.42M | $ -7.41M | $ -1.59M | $ -404.69K | $ -797.34K |
| Operating Cash Flow | $ -11.37M | $ -7.41M | $ -1.59M | $ -404.69K | $ -790.03K |
| Investing Cash Flow | $ -52.09K | $ 0.00 | $ -802.00 | $ 0.00 | $ -7.31K |
| Financing Cash Flow | $ 15.46M | $ 3.23M | $ 18.85M | $ 0.00 | $ 1.05M |
Immix Biopharma, Inc. Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.